Skip to main content
Year archive

Medivir — 2024 filings

All 32 regulatory filings released by Medivir (MVIR) in 2024, sourced directly from the official regulator.

32 Filings
2024 Period
2024 filings (32)
Filing Released Lang
Interim / Quarterly Report 2024
Interim / Quarterly Report 9M 2024
2024-11-06 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report 9M 2024
2024-11-06 English
Medivir meddelar nytt kliniskt studiesamarbets- och supplyavtal med Eisai för att utvärdera fostrox i kombination med lenvatinib vid avancerad levercancer
Regulatory Filings
2024-11-04 Swedish
Medivir announces new clinical trial collaboration and supply agreement with Eisai to evaluate fostrox in combination with lenvatinib in advanced liver cancer
Regulatory Filings
2024-11-04 English
Medivir erhåller en lånefacilitet om 30 miljoner kronor
Capital/Financing Update
2024-10-24 Swedish
Medivir receives loan facility of SEK 30 million
Capital/Financing Update
2024-10-24 English
Interim / Quarterly Report 2024
Interim / Quarterly Report H1 2024
2024-08-22 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report H1 2024
2024-08-22 English
Number of shares and votes in Medivir AB on 28 June 2024
Declaration of Voting Results & Voting Rights Announcements
2024-06-28 English
Antalet aktier och röster i Medivir AB per den 28 juni 2024
Declaration of Voting Results & Voting Rights Announcements
2024-06-28 Swedish
Beslut vid årsstämma i Medivir den 7 maj 2024
AGM Information
2024-05-07 Swedish
Resolutions at the Annual General Meeting in Medivir on 7 May 2024
AGM Information
2024-05-07 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Q1 2024
2024-04-30 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q1 2024
2024-04-30 English
Annual Report (ESEF) 2023
Annual Report (ESEF) FY 2023
2024-04-04 Swedish
Notice of Annual General Meeting of Medivir AB (publ)
AGM Information
2024-04-04 English
Kallelse till årsstämma i Medivir AB (publ)
AGM Information
2024-04-04 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report FY 2023
2024-02-15 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report FY 2023
2024-02-15 English
Number of shares and votes in Medivir AB on 31 January 2024
Declaration of Voting Results & Voting Rights Announcements
2024-01-31 English
Antalet aktier och röster i Medivir AB per den 31 januari 2024
Declaration of Voting Results & Voting Rights Announcements
2024-01-31 Swedish
Major Shareholding Notification 2024
Major Shareholding Notification
2024-01-30 English
Medivir offentliggör utfallet i den riktade nyemissionen som offentliggjordes den 22 januari 2024
Capital/Financing Update
2024-01-26 Swedish
Medivir announces the outcome of the directed share issue which was announced on 22 January 2024
Declaration of Voting Results & Voting Rights Announcements
2024-01-26 English
Medivir carries out a directed share issue of approx. SEK 20 million
Share Issue/Capital Change
2024-01-22 English
Medivir genomför en riktad nyemission om cirka 20 MSEK
Capital/Financing Update
2024-01-22 Swedish
Major Shareholding Notification 2024
Major Shareholding Notification
2024-01-22 Swedish
Major Shareholding Notification 2024
Major Shareholding Notification
2024-01-19 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements
2024-01-12 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements
2024-01-11 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements
2024-01-10 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-01-10 Swedish